Related Experiment Video
Updated: Jul 20, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Diagnosis of celiac disease
Shinjini Bhatnagar1, Nitya Tandon
1Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. shinjini_bhatnagar@rediffmail.com
Celiac disease diagnosis in India is challenging due to varied presentation. Utilizing serological antibodies like anti-tissue transglutaminase and genetic markers (HLA-DQ2/DQ8) improves accurate celiac disease detection.
Area of Science:
- Gastroenterology and Immunology
- Genetic Epidemiology
- Diagnostic Medicine
Background:
- Celiac disease, an immune-mediated enteropathy triggered by gluten in genetically susceptible individuals, is increasingly reported globally, including India.
- Historically, diagnosis relied on small intestinal mucosal biopsy and gluten withdrawal, but evolving epidemiology necessitates refined diagnostic approaches.
- The true prevalence in India remains underestimated due to missed diagnoses, highlighting the need for improved awareness and diagnostic tools.
Framework:
- Celiac disease histopathology ranges from increased intraepithelial lymphocytes to classical villous atrophy, presenting a heterogeneous spectrum.
- The Indian subcontinent exhibits diverse histological presentations, potentially leading to missed diagnoses if solely based on severe changes or if mild/moderate changes lack serological correlation.
- Serological markers, including antiendomysial (Anti EMA) and anti-tissue transglutaminase antibodies (anti-tTGA), offer high sensitivity and specificity (>95%) for diagnosis.
Implementation:
- Anti-tTGA assays are preferred for large-scale screening over operator-dependent Anti EMA tests, though variations in antigen sources and assay techniques can impact accuracy.
- Genetic predisposition is strongly linked to HLA-DQ2 or HLA-DQ8. Over 97% of North Indian celiac patients possess the HLA-DQ2 heterodimer, indicating a significant genetic risk.
- HLA-DQ2 typing serves as a valuable tool for excluding celiac disease in equivocal cases, boasting a negative predictive value exceeding 95%.
Implications:
- The protean clinical manifestations and heterogeneous histology underscore the importance of a standardized diagnostic algorithm for celiac disease.
- Accurate and timely diagnosis is crucial for effective management and preventing long-term complications associated with untreated celiac disease.
- Enhanced diagnostic strategies incorporating serology and genetic markers are vital for improving celiac disease detection rates, particularly in diverse populations like India.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Serum Laboratory Studies, Stool Test, Breath Test
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Pancreatitis II: Collaborative Care
Assessment:
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

